Literature DB >> 2610494

Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.

R E Polk1, D P Healy, J Sahai, L Drwal, E Racht.   

Abstract

Cations such as magnesium and aluminum significantly impair the absorption of ciprofloxacin. Twelve healthy adult male volunteers participated in this four-way crossover study to investigate the effects of ferrous sulfate and multivitamins with zinc on the absorption of ciprofloxacin. Doses of ciprofloxacin (500 mg) were given 7 days apart and after an overnight fast. Dose 1 was administered alone (regimen A). The subjects then received either a ferrous sulfate tablet (325 mg three times a day; regimen B) or a once-daily multivitamin with zinc (regimen C) for 7 days; dose 2 of ciprofloxacin was then given with the last dose of regimen B or C. Subjects were crossed over to the alternate regimen for 7 days, and dose 3 of ciprofloxacin was again administered with the last dose of regimen B or C. After a 7-day washout, dose 4 of ciprofloxacin was given (regimen D). Ciprofloxacin concentrations were determined by high-pressure liquid chromatography. The areas under the concentration-time curve (AUCs) of ciprofloxacin for regimens A and D were not significantly different (14.5 +/- 2.3 versus 15.7 +/- 2.8 micrograms.h/ml, mean +/- standard deviation). The AUCs for regimen B (5.4 +/- 1.7 micrograms.h/ml) and regimen C (11.3 +/- 2.4 micrograms.h/ml) were significantly different from the AUCs for regimens A and D. Peak concentrations of ciprofloxacin with regimen B were below the MIC for 90% of strains of many organisms normally considered susceptible. Ferrous sulfate and multivitamins with zinc significantly impaired the absorption of ciprofloxacin. The effect of ferrous sulfate is likely to be clinically significant; the responsible component of multivitamins with zinc requires additional study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610494      PMCID: PMC172774          DOI: 10.1128/AAC.33.11.1841

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.

Authors:  N Campbell; V Paddock; R Sundaram
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

2.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

3.  Sucralfate reduces the gastrointestinal absorption of norfloxacin.

Authors:  S H Parpia; D E Nix; L G Hejmanowski; H R Goldstein; J H Wilton; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

4.  Liquid-chromatographic determination of ciprofloxacin in serum and urine.

Authors:  D E Nix; J M De Vito; J J Schentag
Journal:  Clin Chem       Date:  1985-05       Impact factor: 8.327

5.  Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.

Authors:  T A Golper; A I Hartstein; V H Morthland; J M Christensen
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 6.  Drug interactions with quinolones.

Authors:  H Lode
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

Review 7.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

8.  Effect of dose size on bioavailability of ciprofloxacin.

Authors:  K I Plaisance; G L Drusano; A Forrest; C I Bustamante; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

10.  Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids.

Authors:  K Timmers; R Sternglanz
Journal:  Bioinorg Chem       Date:  1978-08
View more
  47 in total

1.  In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.

Authors:  H Kita; H Matsuo; H Takanaga; J Kawakami; K Yamamoto; T Iga; M Naito; T Tsuruo; A Asanuma; K Yanagisawa; Y Sawada
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans.

Authors:  K Shiba; O Sakai; J Shimada; O Okazaki; H Aoki; H Hakusui
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

3.  The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin.

Authors:  Yi Ding; Yan-Yan Jia; Fan Li; Wen-Xing Liu; Cheng-Tao Lu; Yan-Rong Zhu; Jing Yang; Li-Kun Ding; Lin Yang; Ai-Dong Wen
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 4.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

5.  Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.

Authors:  T J Lubowski; C Nightingale; K Sweeney; R Quintiliani; J Zhi
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

6.  Inhibition of norfloxacin absorption by dairy products.

Authors:  K T Kivistö; P Ojala-Karlsson; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 7.  The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.

Authors:  C S Lewin; I Morrissey; J T Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 8.  Fluoroquinolones: interaction profile during enteral absorption.

Authors:  K M Deppermann; H Lode
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 9.  Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

10.  Ferrous sulfate reduces cimetidine absorption.

Authors:  N R Campbell; B B Hasinoff; J B Meddings; W D Anderson; S Robertson; K Granberg
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.